Background: Clinical pharmacy is a relatively new field of practice in Indian hospital settings, the health care providers (HCPs) has scarce knowledge regarding the roles & activities of the clinical pharmacist. The objective of this study was to determine the perceptions of health care providers towards clinical pharmacists who work on healthcare teams in terms of the potential benefits of clinical pharmacists and the current expectations of physicians and to explore the barriers that impede the clinical pharmacists' contributions from the physician's point of view. Methodology: The study was conducted as an interventional study in a tertiary care hospital among HCPs (n = 153) in three phases. Pre and post-interventional phase consisted of auditing the behaviour and attitudes of HCPs about clinical pharmacy services and interventional phase consisted of developing professional recognition & professional awareness. The statistical test was performed using the Chi-Square test and analysis of variance (ANOVA). Results: 41.1% of the HCPs stated that they have not heard about clinical pharmacy services. A significantly higher number of physicians prefer face to a face communication system (χ 2 = 6.428, df = 1, p < 0.05) compared to nurses & other HCPs. Lack of clinical pharmacist time was found to be the first barrier to the interprofessional relationship. 48.6% of the physicians reported that they never had open communication with the pharmacist. Conclusion: GPs are aware of the current professional training of clinical pharmacist as being more patient orientated. However, GPs strongly disagreed that clinical pharmacist has the right to set therapeutic decisions or to maintain a complete medication profile of patients.
Pengendalian penyakit tanaman bawang merah hingga saat ini masih mengandalkan fungisida kimia yang dapat mencemari lingkungan, sehingga perlu dilakukan pengendalian secara hayati dan ramah lingkungan. Alternatif yang dapat diterapkan adalah menggunakan Biopestisida Fobio dan agens hayati Trichoderma sp. Tujuan penelitian ini adalah untuk mengetahui respon aplikasi Biopestisida Fobio dan agens hayati Trichoderma sp. terhadap penyakit layu fusarium pada bawang merah. Penelitian dilaksanakan pada bulan Agustus-Oktober 2022 di Kecamatan Kedopok, Kota Probolinggo. Penelitian menggunakan Rancangan Petak Terbagi dengan dua faktor, yaitu konsentrasi Biopestisida Fobio terdiri dari 3 taraf yaitu petak utama adalah F0 (kontrol atau perlakuan pestisida kimia), F1 (Fobio 5 ml/liter), F2 (Fobio 7,5 ml/liter) dan anak petak yaitu konsentrasi Trichoderma sp. terdiri dari 3 taraf yaitu T0 (kontrol atau perlakuan pestisida kimia), T1 (Trichoderma sp. 10 ml/liter), T2 (Trichoderma sp. 20 ml/liter) sehingga terdapat 9 kombinasi perlakuan. Parameter pengamatan meliputi periode inkubasi, kejadian penyakit, berat basah umbi, dan berat kering umbi. Hasil penelitian dari semua kombinasi perlakuan tidak berbeda nyata. Hasil perlakuan aplikasi Biopestisida Fobio menunjukkan bahwa tanaman bawang merah berbeda nyata terhadap periode inkubasi pada perlakuan F2 dengan nilai rata-rata tertinggi yaitu 20 hst. Kejadian penyakit terendah terdapat pada perlakuan F2 pada umur 28 dan 42 hst. Perolehan berat basah paling tinggi diperoleh pada perlakuan F2T0 yaitu 2,128 kg. Perolehan berat kering tertinggi yaitu pada perlakuan F0T2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.